1. Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment
   Leen J. M. Heyens et al, 2021, Frontiers in Medicine CrossRef
2. Astaxanthin attenuates hepatic steatosis in high-fat diet-fed rats by suppressing microRNA-21 via transactivation of nuclear factor erythroid 2-related factor 2
   Abdullah S. Shatoor et al, 2022, Journal of Physiology and Biochemistry CrossRef
3. Aberrant Expressional Profiling of Known MicroRNAs in the Liver of Silver Carp (Hypophthalmichthys molitrix) Following Microcystin-LR Exposure Based on samllRNA Sequencing
   Yiyi Feng et al, 2020, Toxins CrossRef
4. The Critical Role of microRNA-21 in Non-alcoholic Fatty Liver Disease Pathogenesis
   Mingjing Liu et al, 2023, Current Pharmaceutical Design CrossRef
5. Micro RNAs as Emerging Therapeutic Targets in Liver Diseases
   Subheet Kumar Jain et al, 2022, Current Protein & Peptide Science CrossRef
6. Noncoding RNAs as additional mediators of epigenetic regulation in nonalcoholic fatty liver disease
   Mohamed Zaiou, 2022, World Journal of Gastroenterology CrossRef